NeuronAlgo
~/backtests/na-nas-l-001 backtest

$ cd /evidence  ·  evidence archive

Backtest evidence

Altair

code: NA-IDX-079 NasdaQ_Oanda H1 2006-01-02 → 2026-06-19
net $14,104 trades 647 win 47.60%
at-a-glance --summaryok

$ stats --glance

headline performance at a glance

net_profit
Total net profit $14,104
gross profit$54,237
gross loss$40,133
win_rate
47.60%WIN
█████░░░░░
Win rate
307W / 338L
profit_factor
1.35PF
█████░░░░░
Profit factor
gross P / gross L
cagr
4.50%CAGR
██░░░░░░░░
CAGR
annualized
max_drawdown
-39.74%MAX DD
████░░░░░░
Max drawdown
$3,974
equity_curve --renderok

$ plot --equity

cumulative account equity over the test window

Stored snapshot: 648 points; starts at $9,866.10, ends at $24,103.80; observed range $6,025.78–$24,112.44.

x: time · y: equity (USD)● rendered by na-backtest-charts

$ plot --drawdown

underwater equity (peak-to-trough), in account currency — risk per trade is a fixed dollar amount, so a percent axis would shrink every year as the balance grew

x: time · y: drawdown (USD)● rendered by na-backtest-charts
trade_breakdown --analyzepartial

$ trades --breakdown

win/loss split, averages, and streaks

win_loss_split
47.60%win
Wins307
Losses338
Total647
win_vs_loss_size
Avg win$176.67
Avg loss$118.74
Largest win$410.82
Largest loss-$234.90
key_ratios
Profit factor1.35
Win/Loss ratio0.91
Payout ratio1.49
Expectancy$21.80
Avg trade$21.80
Bars in trade7.51
streaks
Max consec wins8
Max consec losses10
Avg consec wins2.02
Avg consec losses2.22
Long vs short breakdown and per-trade distributions are not in the ingested dataset yet.
full_statistics --allok

$ stats --full

complete metric set, grouped by category

$14,104
Net profit
$54,237
Gross profit
$40,133
Gross loss
4.50%
CAGR
6.72
AHPR
$705
Yearly avg profit
$58
Monthly avg profit
$1.89
Daily avg profit
7.05%
Yearly avg return
1.14%
Exposure
647
Trades
$21.80
Avg trade
run.configok

$ cat run.config

parameters used for this run

instrumentNasdaQ_Oanda
timeframeH1
period start2006-01-02
period end2026-06-19
profit in pips66076.04 ticks
strategyview →
Trading financial instruments carries a high level of risk and may not be suitable for all investors. Past performance — including backtested and simulated results — is not indicative of future results. NeuronAlgo provides research and tooling, not financial advice.
nextok

Explore the strategy behind this run

See the full methodology, risk profile, and live track record — or browse every backtest in the library.

Generated from stored backtest metrics · NeuronAlgo research desk

Scroll to Top